IL98223A0 - Pharmaceutical compositions containing fluorene derivatives,some such novel compounds and their preparation - Google Patents
Pharmaceutical compositions containing fluorene derivatives,some such novel compounds and their preparationInfo
- Publication number
- IL98223A0 IL98223A0 IL98223A IL9822391A IL98223A0 IL 98223 A0 IL98223 A0 IL 98223A0 IL 98223 A IL98223 A IL 98223A IL 9822391 A IL9822391 A IL 9822391A IL 98223 A0 IL98223 A0 IL 98223A0
- Authority
- IL
- Israel
- Prior art keywords
- preparation
- pharmaceutical compositions
- compositions containing
- novel compounds
- fluorene derivatives
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 125000003983 fluorenyl group Chemical class C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/51—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/16—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
- C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
- C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
- C07C2603/18—Fluorenes; Hydrogenated fluorenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/40—Ortho- or ortho- and peri-condensed systems containing four condensed rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/529,356 US5079260A (en) | 1989-06-22 | 1990-05-29 | Method for treating inflammation and compounds and compositions suitable for use therein |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL98223A0 true IL98223A0 (en) | 1992-06-21 |
Family
ID=24109577
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL98223A IL98223A0 (en) | 1990-05-29 | 1991-05-22 | Pharmaceutical compositions containing fluorene derivatives,some such novel compounds and their preparation |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5079260A (fr) |
| EP (1) | EP0531443A4 (fr) |
| JP (1) | JPH05509299A (fr) |
| AU (1) | AU7951591A (fr) |
| CA (1) | CA2083134A1 (fr) |
| FI (1) | FI925327A0 (fr) |
| IE (1) | IE911823A1 (fr) |
| IL (1) | IL98223A0 (fr) |
| NZ (1) | NZ238272A (fr) |
| WO (1) | WO1991018596A1 (fr) |
| ZA (1) | ZA914102B (fr) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5668230A (en) * | 1991-07-23 | 1997-09-16 | Phillips Petroleum Company | Olefin polymerization |
| US5472973A (en) * | 1991-12-12 | 1995-12-05 | Scios Nova Inc. | Fluorenyl derivatives as anti-inflammatory agents |
| IL104043A0 (en) * | 1991-12-12 | 1993-05-13 | Scios Nova Inc | Fluorenyl derivatives and pharmaceutical compositions containing them |
| IT1270694B (it) * | 1994-11-15 | 1997-05-07 | Italfarmaco Spa | Derivati fluorenil-idrossammici ad attivita' immunosoppressiva ed antiinfiammatoria |
| US5788982A (en) * | 1995-06-16 | 1998-08-04 | Nadoolman; Wolffe | Method and composition for treating oral pain using capsaicin |
| AU2745700A (en) | 1999-02-01 | 2000-08-18 | Dermal Research Laboratories, Inc. | A pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same |
| WO2001009117A1 (fr) * | 1999-07-29 | 2001-02-08 | Allellix Neuroscience Inc. | Composes tricycliques comme inhibiteurs de transport de glycine |
| US20040082623A1 (en) * | 2000-06-29 | 2004-04-29 | Stephane Rochhi | Fmoc-l-leucine and derivatives thereof as ppar-gamma agonists |
| US7879824B2 (en) | 2001-07-31 | 2011-02-01 | Dermal Research Laboratories, Inc. | Methods of preventing or treating diseases and conditions using complex carbohydrates |
| US20020035104A1 (en) * | 2000-08-18 | 2002-03-21 | Genentech, Inc. | Integrin receptor inhibitors |
| GB0312426D0 (en) * | 2003-05-30 | 2003-07-09 | Albachem Ltd | Purification means |
| CN100412060C (zh) * | 2005-01-27 | 2008-08-20 | 中国科学院大连化学物理研究所 | 2-(n-咔唑基)-乙氧基碳酰肼的制备方法 |
| DE102005062741A1 (de) * | 2005-12-22 | 2007-06-28 | Bayer Schering Pharma Ag | Fluorene und Carbazole als Liganden des EP2 Rezeptors |
| CN101328136B (zh) * | 2008-07-23 | 2011-02-09 | 中国科学院广州化学研究所 | 一种氨基酸酰胺类化合物及其制备方法 |
| CN108774158A (zh) * | 2018-06-20 | 2018-11-09 | 南京肽业生物科技有限公司 | 一种Fmoc和疏水性氨基酸的反应 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2877269A (en) * | 1956-04-17 | 1959-03-10 | Wm S Merrell Co | Guanyl substituted triphenylethanes, triphenylethylenes and benzalfluorenes |
| US3845097A (en) * | 1969-09-06 | 1974-10-29 | Ajinomoto Kk | N-substituted amino acids and novel ester |
| US3919291A (en) * | 1969-09-06 | 1975-11-11 | Ajinomoto Kk | N-ethylcarbaminomethylisoleucine |
| NL7013043A (fr) * | 1969-09-06 | 1971-03-09 | ||
| US3835175A (en) * | 1971-03-15 | 1974-09-10 | Research Corp | 9-fluorenylmethanol haloformates, carbonates and thiocarbonates |
| US3906031A (en) * | 1971-03-15 | 1975-09-16 | Research Corp | Novel 9-fluorenylmethoxycarbonyl compounds |
| EP0129075A3 (fr) * | 1983-05-20 | 1985-08-28 | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft | Dérivés d'amino-acides protégés et leur préparation |
| EP0288965A2 (fr) * | 1987-04-29 | 1988-11-02 | Hoechst Aktiengesellschaft | Peptides inhibant l'activité de phospholipase-A2 |
| JPH04506350A (ja) * | 1989-06-22 | 1992-11-05 | ノバ ファーマスーティカル コーポレイション | 炎症の処置用の医薬組成物及び炎症の処置方法 |
-
1990
- 1990-05-29 US US07/529,356 patent/US5079260A/en not_active Expired - Lifetime
-
1991
- 1991-05-17 EP EP19910911551 patent/EP0531443A4/en not_active Withdrawn
- 1991-05-17 CA CA002083134A patent/CA2083134A1/fr not_active Abandoned
- 1991-05-17 AU AU79515/91A patent/AU7951591A/en not_active Abandoned
- 1991-05-17 WO PCT/US1991/003319 patent/WO1991018596A1/fr not_active Ceased
- 1991-05-17 JP JP3510199A patent/JPH05509299A/ja active Pending
- 1991-05-22 IL IL98223A patent/IL98223A0/xx unknown
- 1991-05-27 NZ NZ238272A patent/NZ238272A/xx unknown
- 1991-05-28 IE IE182391A patent/IE911823A1/en unknown
- 1991-05-29 ZA ZA914102A patent/ZA914102B/xx unknown
-
1992
- 1992-11-24 FI FI925327A patent/FI925327A0/fi not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0531443A4 (en) | 1993-04-21 |
| CA2083134A1 (fr) | 1991-11-30 |
| IE911823A1 (en) | 1991-12-04 |
| US5079260A (en) | 1992-01-07 |
| FI925327A7 (fi) | 1992-11-24 |
| FI925327A0 (fi) | 1992-11-24 |
| ZA914102B (en) | 1993-02-24 |
| NZ238272A (en) | 1994-03-25 |
| EP0531443A1 (fr) | 1993-03-17 |
| WO1991018596A1 (fr) | 1991-12-12 |
| JPH05509299A (ja) | 1993-12-22 |
| AU7951591A (en) | 1991-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL99225A0 (en) | 3-amidopyrazole derivatives,their preparation and pharmaceutical compositions containing them | |
| IL102638A0 (en) | Heterocyclic compounds,their preparation and pharmaceutical compositions containing them | |
| IL103053A0 (en) | Heterocyclic compounds,their preparation and pharmaceutical compositions containing them | |
| ZA923513B (en) | New thiopyranopyrrole derivatives,their preparation and pharmaceutical compositions containing them | |
| IL100262A0 (en) | Alpha-oxoacetamide derivatives,their preparation and pharmaceutical compositions containing them | |
| IL104852A0 (en) | Pharmaceutical compositions containing anthraquinone derivatives,certain such novel compounds and their preparation | |
| IL102175A0 (en) | Imidazodiazepine derivatives,their preparation and pharmaceutical compositions containing them | |
| IL97050A0 (en) | 4-isoxazolecarboxamide derivatives,pharmaceutical compositions containing them and their preparation | |
| IL101380A0 (en) | Bis-naphthalimides,their preparation and pharmaceutical compositions containing them | |
| IL98756A0 (en) | Pharmaceutical compositions containing benzeneacetamid derivatives,certain such novel compounds and their preparation | |
| IL98542A0 (en) | Benzoquinazoline derivatives,their preparation and pharmaceutical compositions containing them | |
| IL98499A0 (en) | Aminobenzodiazepines,their preparation and pharmaceutical compositions containing them | |
| IL100061A0 (en) | Tricyclic compounds,their preparation and pharmaceutical compositions containing them | |
| IL108703A0 (en) | Substituted azolone derivatives, their preparation and pharmaceutical compositions containing them | |
| IL103160A0 (en) | Quinoxaline compounds,their preparation and pharmaceutical compositions containing them | |
| IL98691A0 (en) | Tricyclic compounds containing heteroatoms,their preparation and pharmaceutical compositions containing them | |
| IL102500A0 (en) | 3-deoxy-mannosamine derivatives,their preparation and pharmaceutical compositions containing them | |
| IL110480A0 (en) | Methylguanidine derivatives, their preparation and pharmaceutical compositions containing them | |
| IL104042A0 (en) | Substituted diphenylsulfides,their preparation and pharmaceutical compositions containing them | |
| IL99637A0 (en) | 5h-benzodiazepine derivative,its preparation and pharmaceutical compositions containing it | |
| IL99561A0 (en) | Heterocyclic compounds,their preparation and pharmaceutical compositions containing them | |
| IL102116A0 (en) | Hetaryloxy-beta-carboline derivatives,processes for the preparation thereof,and pharmaceutical compositions containing the same | |
| IL101164A0 (en) | Heterocyclic compounds,their preparation and pharmaceutical compositions containing them | |
| IL103698A0 (en) | Heterocyclic compounds,their preparation and pharmaceutical compositions containing them | |
| IL99551A0 (en) | Tricyclic compounds,processes for the preparation thereof and pharmaceutical compositions containing the same |